Insurance cover
What NHIS pays for Carbamazepine Sustained-Release
Carbamazepine Sustained-Release (Carbamazepine Sustained-Release Tablet, 200 mg Tablet) is on the National Health Insurance Scheme medicines list, edition March 2025. The scheme reimburses providers ₵2.92 per 200 mg Tablet. It may be prescribed from District hospital level upward (District hospital and above). This is the scheme tariff, not a retail price.
Record
CARBAMTA3Generic
Carbamazepine Sustained-Release
Presentation
Carbamazepine Sustained-Release Tablet, 200 mg Tablet
NHIS tariff
₵2.92
Level of prescribing
C · District hospital
Scheme code
CARBAMTA3
List edition
March 2025